Updated on 2023/10/20

写真a

 
Uchikado Yasuto
 
Organization
University Hospital, Medical and Dental Sciences Area University Hospital Management Facilities

Degree

  • 博士（医学） ( 2005.12   鹿児島大学 )

Research Interests

  • patient safety

Research Areas

  • Life Science / Digestive surgery

Research History

  • Kagoshima University

    2015.4

  • Kagoshima University   Assistant Professor

    2007.7 - 2015.3

Professional Memberships

  • Japanese Society for Quality and Safety in Healthcare

    2015.4

  • The Japanese Association for Thoracic Surgery

    2009.9

  • The Japan Esophageal Society

    2002.12

  • Japan Surgical Society

    1997.6

  • The Japanese Society of Gastroenterological Surgery

    1997.6

 

Papers

  • Sasaki K, Tsuruda Y, Shimonosono M, Noda M, Uchikado Y, Omoto I, Setoyama T, Matsushita D, Arigami T, Baba K, Kurahara H, Ohtsuka T .  Comparison of the subtotal and narrow gastric conduit for cervical esophagogastrostomy after esophagectomy in esophageal cancer patients: a propensity score-matched analysis. .  Esophagus : official journal of the Japan Esophageal Society   2023.10Comparison of the subtotal and narrow gastric conduit for cervical esophagogastrostomy after esophagectomy in esophageal cancer patients: a propensity score-matched analysis.

    　More details

    Language：English  

    DOI： 10.1007/s10388-023-01027-7

    PubMed

  • Sasaki K., Tsuruda Y., Shimonosono M., Noda M., Uchikado Y., Arigami T., Matsushita D., Kita Y., Mori S., Kurahara H., Nakajo A., Ohtsuka T. .  A comparison of the surgical invasiveness and short-term outcomes between thoracoscopic and pneumatic mediastinoscopic esophagectomy for esophageal cancer .  Surgery Today52 ( 12 ) 1759 - 1765   2022.12

    　More details

    Language：Japanese   Publisher：Surgery Today  

    Purpose: Minimally invasive esophagectomy (MIE) has been widely accepted as a treatment for esophageal cancer. This retrospective study compared the short-term outcomes and surgical invasiveness between thoracoscopic esophagectomy (TE) and mediastinoscopic esophagectomy with pneumomediastinum (pneumatic mediastinoscopic esophagectomy [PME]). Methods: A total of 72 patients who underwent TE or PME were included and assessed for their surgical findings, postoperative complications, and inflammatory responses on postoperative day (POD) 1, 3, 5, and 7. Results: The PME group exhibited a significantly shorter operative time and fewer lymph nodes retrieved than the TE group. Furthermore, the PME group tended to have greater incidences of recurrent laryngeal nerve palsy and lower incidences of atelectasis than the TE group. The PME group had significantly lower white blood cell counts on POD 5, serum C-reactive protein (CRP) levels on POD 3 than the TE group. Conclusion: PME seems to be less invasive than TE and can be considered the preferred option for patients with lower-stage esophageal cancer expected to have severe pleural adhesion or who cannot tolerate TE.

    DOI： 10.1007/s00595-022-02509-4

    Scopus

    PubMed

  • Shimonosono M., Sasaki K., Tsuruda Y., Noda M., Uchikado Y., Arigami T., Matsushita D., Mori S., Kurahara H., Nakajo A., Ohtsuka T. .  Clinical Outcome After Esophagectomy or Definitive Chemoradiotherapy in Elderly Patients (≥80 Years) With Esophageal Cancer .  Anticancer Research42 ( 8 ) 3953 - 3961   2022.8

    　More details

    Language：Japanese   Publisher：Anticancer Research  

    Background/Aim: Given the increased incidence of esophageal cancer (EC) in individuals over 80 years old, the optimum therapeutic strategy for elderly patients is needed to be established with scientific evidence. Here, we studied the short-term and long-term outcomes after treatment of patients aged 80 years old or older with EC. Patients and Methods: Eighty patients with EC aged 80 years old or older, who underwent esophagectomy (n=23), definitive chemoradiotherapy (dCRT) (n=46) or best supportive care (n=11) between January 2010 and March 2019 were included in this study, and clinical data were compared among these groups. Results: Surgery had a great benefit on the 3-year overall survival (OS) compared to dCRT (68.4% vs. 29.3%, p<0.01). The cure rates of treatment were 86.9% in surgery and 34.8% in dCRT. dCRT led to a better 3-year OS compared to BSC (29.3% vs. 0%, p<0.01); however, dCRT did not improved OS in patients with T4. Patients with T4 had high frequency of adverse events and treatment-related death in dCRT; CTCAE Grade 3-5 was observed in 100% of all T4 patients and Grade 5 in 57.1%. Multivariate analysis revealed that T4 was an independent risk factor of treatment-related death after dCRT (p<0.01). Conclusion: Surgery is the first treatment option for resectable EC even in elderly patients, and dCRT can be considered as an alternative. However, dCRT may induce severe toxicity especially in T4 EC patients.

    DOI： 10.21873/anticanres.15890

    Scopus

    PubMed

  • Sasaki K., Tsuruda Y., Shimonosono M., Noda M., Uchikado Y., Arigami T., Matsushita D., Mori S., Nakajo A., Kurahara H., Ohtsuka T. .  Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma .  Anticancer Research42 ( 8 ) 3905 - 3911   2022.8

    　More details

    Language：Japanese   Publisher：Anticancer Research  

    Background/Aim: To further improve the prognosis of locally advanced esophageal cancer patients, investigating new perioperative treatment strategies is necessary. The current study aimed to retrospectively investigate neoadjuvant radiotherapy with cisplatin and 5-fluorouracil (CF-RT) and radiotherapy with docetaxel and CF (DCF-RT) and compare their treatment outcomes in patients with locally advanced esophageal squamous cell carcinoma (ESCC). Patients and Methods: We retrospectively reviewed 95 patients with ESCC who received CF-RT or DCF-RT followed by esophagectomy. The CF-RT group received chemotherapy consisting of two courses of CF repeated every 4 weeks. The DCF-RT group received chemotherapy consisting of two courses of DCF repeated every 2 weeks. A radiotherapy dose of 1.8-2 Gy was administered per session, up to a total of 40-41.4 Gy. Adverse events of neoadjuvant chemoradiotherapy, surgical outcomes, pathological responses, prognosis, and recurrence patterns were evaluated. Results: Both the CF-RT and DCF-RT groups had equivalent pathological complete response rates of the primary tumor at 31.6% and 38.6%, respectively. However, the DCF-RT group had significantly better 5-year disease-free survival and 5-year overall survival than (HR=0.50, 95%CI=0.26-0.97, p=0.0392) than the CF-RT group. Conclusion: DCF-RT may be a candidate neoadjuvant therapy for locally advanced ESCC.

    DOI： 10.21873/anticanres.15884

    Scopus

    PubMed

  • Matsumoto R., Sasaki K., Noda M., Tsuruda Y., Kita Y., Uchikado Y., Matsushita D., Arigami T., Mori S., Ohtsuka T. .  Successful thoracoscopic resection of an esophageal bronchogenic cyst .  General Thoracic and Cardiovascular Surgery70 ( 1 ) 100 - 103   2022.1

    　More details

    Language：Japanese   Publisher：General Thoracic and Cardiovascular Surgery  

    Esophageal bronchogenic cysts are rare, and since a limited number of cases has been reported, the treatment plan for asymptomatic patients is difficult. A 55-year-old man without any symptoms visited our hospital for further examination of an esophageal mass detected on simple computed tomography. Upper endoscopy showed the protruding, submucosal mass covered by normal mucosa, and endoscopic sonography confirmed hypoechoic lesions originating from the muscularis propria. The patient was diagnosed as having an esophageal duplication cyst and underwent thoracoscopic resection. Pathological findings were consistent with an esophageal bronchogenic cyst. The patient was discharged without any problems on the 6th postoperative day. Upper endoscopy was performed 6 months after surgery, and no evidence of esophageal diverticula or narrowing was present. In conclusion, early thoracoscopic resection of esophageal bronchogenic cysts, before appearance of the symptom, can be a considerable treatment option because it is less invasive and may be advantageous for obtaining a definitive diagnosis in patients who are candidates for safe surgical resection.

    DOI： 10.1007/s11748-021-01694-2

    Scopus

    PubMed

  • Sasaki K. .  Comparison of greater curvature and lesser curvature circular-stapled esophagogastrostomy after esophagectomy in patients with esophageal cancer: a prospective randomized controlled trial .  Surgery Today51 ( 4 ) 575 - 581   2021.4Reviewed

    　More details

    Publisher：Surgery Today  

    DOI： 10.1007/s00595-020-02147-8

    Scopus

    PubMed

  • Hozaka Y, Sasaki K, Nishikawa T, Onishi S, Noda M, Tsuruda Y, Uchikado Y, Kita Y, Arigami T, Mori S, Maemura K, Ieiri S, Kawano Y, Natsugoe S, Ohtsuka T .  Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report. .  Surgical case reports7 ( 1 ) 41   2021.2Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report.

    　More details

    Language：English  

    DOI： 10.1186/s40792-021-01108-8

    PubMed

  • SASAKI K. .  Clinical outcomes of fully covered self-expanding metallic stent placement for palliation of incurable esophageal cancer with or without radiotherapy .  Anticancer Research41 ( 1 ) 385 - 389   2021.1Reviewed

    　More details

    Publisher：Anticancer Research  

    DOI： 10.21873/anticanres.14787

    Scopus

    PubMed

  • Sasaki K, Noda M, Tsuruda Y, Uchikado Y, Omoto I, Kita Y, Arigami T, Mori S, Kurahara H, Nakajo A, Higashi M, Ohtsuka T .  Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review. .  Surgical case reports6 ( 1 ) 176   2020.7Primary monophasic synovial sarcoma of the cervical esophagus confirmed by detection of the SS18-SSX2 fusion transcripts: case report and literature review.Reviewed

    　More details

  • Tanaka T, Arigami T, Uenosono Y, Yanagita S, Matsushita D, Okubo K, Kijima T, Uchikado Y, Kita Y, Mori S, Sasaki K, Omoto I, Kurahara H, Maemura K, Ishigami S, Natsugoe S .  A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report. .  Surgical case reports6 ( 1 ) 13   2020.1A long-term survivor of recurrent esophagogastric junction adenocarcinoma treated with multidisciplinary therapy: a case report.Reviewed

    　More details

  • 内門 泰斗, 尾本 至, 佐々木 健, 有上 貴明, 大脇 哲洋, 前村 公成, 夏越 祥次 .  医療安全-患者と医師が信頼しあえる外科医療を目指して　レジリエンスに基づいた消化器外科手術における医療安全への取り組み .  日本外科学会雑誌121 ( 1 ) 123 - 124   2020.1医療安全-患者と医師が信頼しあえる外科医療を目指して　レジリエンスに基づいた消化器外科手術における医療安全への取り組み

    　More details

    Language：Japanese   Publishing type：Research paper (other academic)  

  • 内門 泰斗 .  【手術室の安全文化促進】消化器外科手術における医療安全レジリエンスの取り組み .  病院安全教育7 ( 3 ) 31 - 36   2019.12【手術室の安全文化促進】消化器外科手術における医療安全レジリエンスの取り組みInvited

    　More details

    Language：Japanese   Publishing type：Research paper (scientific journal)  

  • Matsumoto Ryu, Sasaki Ken, Omoto Itaru, Noda Masahiro, Uchikado Yasuto, Arigami Takaaki, Kita Yoshiaki, Mori Shinichiro, Maemura Kosei, Natsugoe Shoji .  特発性胸腔内食道穿孔に対するチェックバルブ付き被覆食道ステントの一時的留置による保存的治療の成功　1症例報告(Successful conservative treatment of spontaneous intrathoracic esophageal perforation using a temporary covered esophageal stent with a check valve: a case report) .  Surgical Case Reports5   1 of 6 - 6 of 6   2019.10特発性胸腔内食道穿孔に対するチェックバルブ付き被覆食道ステントの一時的留置による保存的治療の成功　1症例報告(Successful conservative treatment of spontaneous intrathoracic esophageal perforation using a temporary covered esophageal stent with a check valve: a case report)

    　More details

    Publisher：Springer Berlin Heidelberg  

    嘔吐後に左胸痛および背部痛を訴えた60歳男性症例について検討した。CTおよび胸部X線検査にて、左緊張性気胸、縦隔気腫、両側胸水が示され、特発性胸腔内食道穿孔が疑われた。急性呼吸不全を伴う敗血症性ショックが発現した。外科的治療は侵襲性が高いと考え、食道ステントによる保存的治療を選択した。全身麻酔下で左後胸腔に20-Frのトロカールを挿入し、暗色の胸水を大量に排出した。内視鏡検査を実施し、食道下部の左後外側壁にpinhole状の穿孔を認めた。チェックバルブ付きシリコン被覆食道ステントと2成分栄養剤(W-ED)チューブの両方を挿入した。18-Frのトロカールを左前壁に挿入した。これらの処置は発現後24時間以内に実施した。集中治療としては、広域抗生物質およびcatecholamineを投与した。トロカール2本およびW-EDチューブは、30秒ごとに-5cmH2Oおよび-20cmH2Oで継続的に吸引した。6日目にCTガイド下で左胸膜に胸腔ドレナージチューブを追加挿入した。ほぼ3週間ごとにステントを抜去し、食道穿孔は45日目に完全に治癒した。患者は70日目に退院した。

  • Hirahara T. .  Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer .  BMC Cancer19 ( 1 ) 672   2019.7Reviewed

    　More details

    Publisher：BMC Cancer  

    DOI： 10.1186/s12885-019-5903-y

    Scopus

    PubMed

  • Nepal P. .  Combined endoscopic submucosal dissection and transanal minimally invasive surgery for the management of lower rectal adenoma extending above the dentate line: A case report .  Medicine98 ( 19 ) e15289   2019.5

    　More details

  • Sasaki K. .  Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-RT) for locally advanced esophageal squamous cell carcinoma .  Cancer Chemotherapy and Pharmacology83 ( 3 ) 581 - 587   2019.3Reviewed

    　More details

    Publisher：Cancer Chemotherapy and Pharmacology  

    DOI： 10.1007/s00280-018-03764-4

    Scopus

    PubMed

  • Shimonosono M. .  Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR-145-3p on gene regulation .  International Journal of Oncology54 ( 2 ) 673 - 688   2019.2Reviewed

    　More details

    Publisher：International Journal of Oncology  

    DOI： 10.3892/ijo.2018.4657

    Scopus

    PubMed

  • 内門 泰斗, 夏越 祥次 .  【食道癌(第2版)-基礎・臨床研究の進歩-】食道癌の治療　外科治療　医療安全から見た食道癌手術 .  日本臨床76 ( 8 ) 357 - 362   2018.10【食道癌(第2版)-基礎・臨床研究の進歩-】食道癌の治療　外科治療　医療安全から見た食道癌手術Invited

    　More details

    Authorship：Lead author   Language：Japanese   Publishing type：Research paper (scientific journal)  

  • Arigami T. .  Primary tumor score based on tumor depth and length predicts prognosis in esophageal squamous cell carcinoma .  Anticancer Research38 ( 9 ) 5447 - 5452   2018.9Reviewed

    　More details

    Publisher：Anticancer Research  

    DOI： 10.21873/anticanres.12876

    Scopus

    PubMed

  • Higo N. .  Expression of SOX9 is related to prognosis in patients with oesophageal squamous cell carcinoma .  In Vivo32 ( 4 ) 835 - 838   2018.7Reviewed

    　More details

    Publisher：In Vivo  

    DOI： 10.21873/invivo.11316

    Scopus

    PubMed

  • Shimonosono M. .  The association of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2) expression with gastric cancer prognosis .  Oncotarget9 ( 31 ) 22069 - 22078   2018.4Reviewed

    　More details

    Publisher：Oncotarget  

    DOI： 10.18632/oncotarget.25179

    Scopus

    PubMed

  • Sasaki K, Uchikado Y, Omoto I, Amatatsu M, Megumi K, Okumura H, Maemura K, Natsugoe S .  Multidisciplinary therapy for metastatic primary malignant melanoma of the esophagus: A case report. .  Molecular and clinical oncology8 ( 4 ) 528 - 532   2018.4Multidisciplinary therapy for metastatic primary malignant melanoma of the esophagus: A case report.Reviewed

    　More details

  • Hozaka Y. .  Curative resection for unresectable locally advanced colorectal cancer following intensive chemotherapy plus molecular targeted agent-report of three cases .  Japanese Journal of Cancer and Chemotherapy45 ( 4 ) 670 - 672   2018.4

    　More details

    Publisher：Japanese Journal of Cancer and Chemotherapy  

    Scopus

  • Hozaka Y, Mori S, Kita Y, Baba K, Arigami T, Uenosono Y, Uchikado Y, Mataki Y, Maemura K, Natsugoe S .  [Curative Resection for Unresectable Locally Advanced Colorectal Cancer Following Intensive Chemotherapy plus Molecular Targeted Agent - Report of Three Cases]. .  Gan to kagaku ryoho. Cancer & chemotherapy45 ( 4 ) 670 - 672   2018.4[Curative Resection for Unresectable Locally Advanced Colorectal Cancer Following Intensive Chemotherapy plus Molecular Targeted Agent - Report of Three Cases].

    　More details

  • Mori S. .  Laparoscopic complete mesocolic excision via mesofascial separation for left-sided colon cancer .  Surgery Today48 ( 3 ) 274 - 281   2018.3Reviewed

    　More details

    Publisher：Surgery Today  

    DOI： 10.1007/s00595-017-1580-0

    Scopus

    PubMed

  • Noda M. .  Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma .  Annals of Surgical Oncology25 ( 2 ) 449 - 455   2018.2Reviewed

    　More details

    Publisher：Annals of Surgical Oncology  

    DOI： 10.1245/s10434-017-6271-y

    Scopus

    PubMed

  • Yanagi M. .  Effect of neoadjuvant chemoradiotherapy on lymph node micrometastases in thoracic esophageal cancer .  Anticancer Research38 ( 2 ) 893 - 900   2018.2Reviewed

    　More details

    Publisher：Anticancer Research  

    DOI： 10.21873/anticanres.12299

    Scopus

    PubMed

  • Haraguchi N. .  Clinical significance of primary tumor score determined by tumor depth and size in patients with resectable gastric cancer .  Oncotarget9 ( 9 ) 8512 - 8520   2018Reviewed

    　More details

    Publisher：Oncotarget  

    DOI： 10.18632/oncotarget.23953

    Scopus

    PubMed

  • Osako Y. .  Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma .  Journal of Human Genetics62 ( 11 ) 935 - 944   2017.11Reviewed

    　More details

    Publisher：Journal of Human Genetics  

    DOI： 10.1038/jhg.2017.69

    Scopus

    PubMed

  • Tsuruda Y, Okumura H, Setoyama T, Hiwatashi K, Minami K, Maenohara S, Uchikado Y, Omoto I, Sasaki K, Natsugoe S .  [Case Report of an Acute Focal Bacterial Nephritis Associated with Adjuvant Chemotherapy in Esophageal Cancer Patient]. .  Gan to kagaku ryoho. Cancer & chemotherapy44 ( 12 ) 1476 - 1478   2017.11[Case Report of an Acute Focal Bacterial Nephritis Associated with Adjuvant Chemotherapy in Esophageal Cancer Patient].

    　More details

  • Okubo K. .  Clinical significance of altering epithelial–mesenchymal transition in metastatic lymph nodes of gastric cancer .  Gastric Cancer20 ( 5 ) 802 - 810   2017.9Reviewed

    　More details

    Publisher：Gastric Cancer  

    DOI： 10.1007/s10120-017-0705-x

    Scopus

    PubMed

  • Mori S. .  Laparoscopic complete mesocolic excision via combined medial and cranial approaches for transverse colon cancer .  Surgery Today47 ( 5 ) 643 - 649   2017.5Reviewed

    　More details

    Publisher：Surgery Today  

    DOI： 10.1007/s00595-016-1409-2

    Scopus

    PubMed

  • Desaki R. .  As a Novel Prognostic Marker, Cysteine/histidine-rich 1 (CYHR1) is a Therapeutic Target in Patients with Esophageal Squamous Cell Carcinoma .  Annals of Surgical Oncology24 ( 2 ) 586 - 593   2017.2Reviewed

    　More details

    Publisher：Annals of Surgical Oncology  

    DOI： 10.1245/s10434-015-5031-0

    Scopus

    PubMed

  • Kijima T. .  Combined fibrinogen and neutrophil-lymphocyte ratio as a prognostic marker of advanced esophageal squamous cell carcinoma .  Cancer Science108 ( 2 ) 193 - 199   2017.2Reviewed

    　More details

    Publisher：Cancer Science  

    DOI： 10.1111/cas.13127

    Scopus

    PubMed

  • Nakajo A. .  Bidirectional Approach of Video-Assisted Neck Surgery (BAVANS): Endoscopic complete central node dissection with craniocaudal view for treatment of thyroid cancer .  Asian journal of endoscopic surgery10 ( 1 ) 40 - 46   2017.2Reviewed

    　More details

    Publisher：Asian journal of endoscopic surgery  

    DOI： 10.1111/ases.12312

    Scopus

    PubMed

  • Maemura K. .  Gemcitabine and S-1 induction chemotherapy followed by chemoradiotherapy for locally advanced pancreatic cancers .  Anticancer Research37 ( 1 ) 233 - 237   2017.1Reviewed

    　More details

    Publisher：Anticancer Research  

    DOI： 10.21873/anticanres.11312

    Scopus

    PubMed

  • Tanabe K. .  Filamin C promotes lymphatic invasion and lymphatic metastasis and increases cell motility by regulating Rho GTPase in esophageal squamous cell carcinoma .  Oncotarget8 ( 4 ) 6353 - 6363   2017Reviewed

    　More details

    Publisher：Oncotarget  

    DOI： 10.18632/oncotarget.14087

    Scopus

    PubMed

  • Sasaki K. .  Role of <sup>18</sup>F-FDG-PET/CT in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy .  Anticancer Research37 ( 2 ) 859 - 864   2017Reviewed

    　More details

    Publisher：Anticancer Research  

    DOI： 10.21873/anticanres.11390

    Scopus

    PubMed

  • Uchikado Y, Okumura H, Ishigami S, Setoyama T, Matsumoto M, Owaki T, Kita Y, Natsugoe S .  Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. .  Gastric Cancer14 ( 1 ) 41 - 49   2011.3Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer.Reviewed

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Uchikado Y, Inoue H, Haraguchi N, Mimori K, Natsugoe S, Okumura H, Aikou T, Mori M .  Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. .  Int J Oncol.29 ( 6 ) 1337 - 1347   2006.12Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma.Reviewed

    　More details

    Language：English   Publishing type：Research paper (scientific journal)  

  • Uchikado Y, Natsugoe S, Okumura H, Setoyama T, Matsumoto M, Ishigami S, Aikou T. .  Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma. .  Clin Cancer Res.11 ( 3 ) 1174 - 1180   2005.2Slug Expression in the E-cadherin preserved tumors is related to prognosis in patients with esophageal squamous cell carcinoma.Reviewed

    　More details

    Language：English   Publishing type：Doctoral thesis  

    Purpose: The expression of E-cadherin correlates with the development, progression, and metastasis of esophageal squamous cell carcinoma (ESCC). Slug, a member of the snail family of transcriptional factors, is a newly identified suppressive transcriptional factor of E-cadherin. The purpose of the present study was to evaluate the clinical significance of E-cadherin and Slug expression in ESCC.
    Experimental design: Immunohistochemistry was used to investigate the expression of E-cadherin and Slug proteins in 203 patients with ESCC. The relationships between expression of these proteins and clinicopathologic factors, including prognosis, were analyzed.
    Results: Positive expression of E-cadherin and Slug was observed in 43% and 48% of cases, respectively. The tumors with reduced E-cadherin expression or positive Slug expression invaded deeper, had more lymph node metastasis, and had more lymphatic invasion than the tumors with preserved E-cadherin expression or negative Slug expression. Slug expression significantly correlated with reduced E-cadherin expression. Sixty-seven of the 98 (68.4%) tumors with positive Slug expression had reduced E-cadherin expression (P = 0.0011). Patients with reduced E-cadherin expression or positive Slug expression had poor clinical outcomes. In the preserved E-cadherin group, the 5-year survival rate was better for patients who were negative for Slug expression than for those who were positive for Slug expression (P = 0.035). Multivariate analysis indicated that E-cadherin expression and Slug expression were not independent prognostic factors.
    Conclusions: Evaluation of not only the expression of E-cadherin but also the co-expression of E-cadherin and Slug in preserved E-cadherin group is useful for predicting malignant properties of ESCC.

▼display all

MISC

  • 医療安全　安心・安全な医療のための医療安全活動

    内門 泰斗, 夏越 祥次

    日本外科学会雑誌   119 ( 2 )   219 - 220   2018.3

    　More details

    Publisher：(一社)日本外科学会  

  • 【食道癌手術-最新技術】頸部食道癌の喉頭温存手術

    内門 泰斗, 尾本 至, 佐々木 健, 有上 貴明, 上之園 芳一, 夏越 祥次

    手術   71 ( 5 )   753 - 758   2017.4

    　More details

    Publisher：金原出版(株)  

Presentations

  • 内門 泰斗, 尾本 至, 佐々木 健, 有上 貴明, 上之園 芳一, 奥村 浩, 夏越 祥次   鹿児島大学病院における高難度新規医療技術を用いた医療提供への取り組み  

    日本外科学会定期学術集会抄録集  2017.4  (一社)日本外科学会

  • 内門 泰斗, 夏越 祥次   鹿児島大学病院　消化器外科診療における医療安全への取り組み  

    日本消化器外科学会総会  2018.7  (一社)日本消化器外科学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 野田 昌宏, 大脇 哲洋, 奥村 浩, 大迫 祐作, 喜多 芳昭, 瀬戸山 徹郎, 夏越 祥次   食道癌手術における肺癌重複例の術式選択について  

    日本食道学会学術集会プログラム・抄録集  2019.6  (NPO)日本食道学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 喜多 芳昭, 大脇 哲洋, 瀬戸山 徹郎, 奥村 浩, 石神 純也, 夏越 祥次   頸部食道癌に対する集学的治療の重要性  

    日本食道学会学術集会プログラム・抄録集  2018.6  (NPO)日本食道学会

  • 内門 泰斗, 福島 悦子, 今川 真由美, 西澤 由紀彦, 川畑 美賀, 武田 文夫, 長尾 能雅, 深見 達弥, 寺井 美峰子, 古谷 健夫   術前休薬を要する薬剤が中止されず手術延期となる件数をゼロにする  

    医療の質・安全学会誌  2020.11  (一社)医療の質・安全学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 大脇 哲洋, 奥村 浩, 喜多 芳昭, 有上 貴明, 柳田 茂寛, 前村 公成, 夏越 祥次   胸部食道癌の頸部吻合再建後の頸部ドレーン留置の現状  

    日本消化器外科学会総会  2019.7  (一社)日本消化器外科学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 大脇 哲洋, 奥村 浩, 喜多 芳昭, 盛 真一郎, 有上 貴明, 柳田 茂寛, 石神 純也, 大迫 祐作, 夏越 祥次   胸部食道癌の頸部吻合再建における頸部ドレーンの抜去時期について  

    日本消化器外科学会雑誌  2018.11  (一社)日本消化器外科学会

  • 内門 泰斗, 今川 真由美, 福島 悦子, 古田 貴志, 大吉 達樹, 浜田 倫史, 大石 充   放射線・病理診断報告書の確実な確認のための対策  

    医療の質・安全学会誌  2019.11  (一社)医療の質・安全学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 喜多 芳昭, 大脇 哲洋, 有上 貴明, 上之園 芳一, 盛 真一郎, 浦田 正和, 奥村 浩, 石神 純也, 夏越 祥次   外科系医師のインシデント報告の現状と報告推進の取り組み  

    日本外科系連合学会誌  2017.5  日本外科系連合学会

  • 内門 泰斗, 今川 真由美, 福島 悦子, 古田 貴志, 大吉 達樹, 浜田 倫史, 大石 充, 井本 浩, 佐藤 雅美, 家入 里志, 夏越 祥次   外科治療に求められる医療安全　患者・多職種連携で取り組む外科手術の医療安全  

    日本外科系連合学会誌  2020.12  日本外科系連合学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 有上 貴明, 大脇 哲洋, 前村 公成, 夏越 祥次   レジリエンスに基づいた消化器外科手術における医療安全への取り組み  

    日本外科学会定期学術集会抄録集  2019.4  (一社)日本外科学会

  • 内門 泰斗, 尾本 至, 佐々木 健, 喜多 芳昭, 大脇 哲洋, 奥村 浩, 石神 純也, 有上 貴明, 上之園 芳一, 夏越 祥次   サルベージ手術の術後合併症予防、再発予測  

    日本食道学会学術集会プログラム・抄録集  2017.6  (NPO)日本食道学会

  • 西澤 由紀彦, 内門 泰斗, 古田 貴志, 肥後 昌代, 福島 悦子, 日高 朋, 井上 和啓, 寺薗 英之, 石塚 賢治, 武田 泰生   高濃度カリウム製剤使用の標準化における薬剤師GRMとしての関わり  

    医療の質・安全学会誌  2021.11  (一社)医療の質・安全学会

    　More details

    Language：Japanese  

  • 内門 泰斗, 福島 悦子, 肥後 昌代, 佐潟 芳久, 藏元 直也, 西澤 由紀彦, 宮腰 昌明, 市来 仁志, 石塚 賢治   適切なモニター管理と運用を目指したモニターアラームコントロールチームの取り組み  

    医療の質・安全学会誌  2021.11  (一社)医療の質・安全学会

    　More details

    Language：Japanese  

▼display all

Research Projects

  • Search for N-type sugar chain markers that enable personalized treatment and prognosis for esophageal cancer

    2016.4 - 2019.3

    Grant-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research(C)